EUVIMEDEUVIMED entdecken
Open Access

Bayesian-Based Pharmacokinetic Framework Integrated with Therapeutic Drug Monitoring for Assessing Adherence to Antiseizure Medications: A Clinical Trial Simulation Study

Xiao-Qin Liu, Zi-Ran Li, Wei-Wei Lin, Juan Wang, Fu-Qing Gu, Jun-Jie Ding, Zheng Jiao

Journal of Medical Internet Research · 2026

DOI: 10.2196/77917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Internet Research, 2026. Verfasst von Xiao-Qin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, 241 West Huaihai Road, Shanghai, 200030, China, 86…. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Monitoring, Medication Adherence, Epilepsy. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adherence to antiseizure medications (ASMs) is a cornerstone of effective epilepsy management. However, current consensus guidelines for assessing medication adherence via therapeutic drug monitoring (TDM) may neglect individual patient characteristics, thereby compromising the accuracy of adherence assessments.

Objective

This study proposed an innovative Bayesian–based pharmacokinetic (PK) framework integrated with TDM data to address the above limitations, with a focus on 14 widely prescribed ASMs, including brivaracetam, carbamazepine, clobazam, eslicarbazepine acetate, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital, topiramate, valproic acid, vigabatrin, and zonisamide.

Methods

Comprehensive clinical trial simulations were conducted to investigate the PK of ASMs in patients with epilepsy under conditions of full adherence and various nonadherent dosing behaviors, including omission of the last dose and consecutive missed doses. Bayesian posterior probabilities of these dosing behaviors were derived by integrating validated population PK models, individual patient demographics (eg, age, weight, creatinine clearance), dosing history, prior adherence probabilities and TDM measurements. Additionally, the influence of covariates on assessment outcomes was systematically evaluated.

Results

The Bayesian-based PK approach demonstrated robust discriminative ability. Under idealized simulation conditions with minimized variabilities, the approach achieved accurate retrodiction of the last 1 or 2 doses across all 14 ASMs and partial retrodiction of extended nonadherence trajectories for 6 ASMs. Concentration thresholds for adherence classification varied significantly across drugs and are influenced by patient-specific factors, comedications, formulation, sampling time, and prior probability. To translate these insights into practice, an adaptable web-based dashboard was developed using the shiny package in R software to enable precise and real-time assessments of medication adherence.

Conclusions

This study establishes a Bayesian-based PK approach to enhance the assessment of ASMs adherence. This approach facilitates a paradigm shift from population-based management to patient-specific adherence profiling, offering a practical methodology for the precise evaluation of medication-taking behaviors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsDrug MonitoringMedication AdherenceEpilepsyHumansBayes TheoremComputer SimulationAdultMaleFemaleMiddle Aged

Stichwörter der Autor:innen

Bayesian theoryantiseizure medicationsmedication adherencepopulation pharmacokineticstherapeutic drug monitoring

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, 241 West Huaihai Road, Shanghai, 200030, China, 86 15502125571.
  • Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States.
  • Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Center for Tropical Disease and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.

Zitieren

APA

Liu, X. Q., Li, Z. R., Lin, W. W., Wang, J., Gu, F. Q., Ding, J. J., & Jiao, Z. (2026). Bayesian-Based Pharmacokinetic Framework Integrated with Therapeutic Drug Monitoring for Assessing Adherence to Antiseizure Medications: A Clinical Trial Simulation Study. Journal of Medical Internet Research. https://doi.org/10.2196/77917

Vancouver

Liu XQ, Li ZR, Lin WW, Wang J, Gu FQ, Ding JJ, et al. Bayesian-Based Pharmacokinetic Framework Integrated with Therapeutic Drug Monitoring for Assessing Adherence to Antiseizure Medications: A Clinical Trial Simulation Study. Journal of Medical Internet Research. 2026. doi:10.2196/77917

BibTeX
@article{Liu2026,
  author = {Liu, Xiao-Qin and Li, Zi-Ran and Lin, Wei-Wei and Wang, Juan and Gu, Fu-Qing and Ding, Jun-Jie and Jiao, Zheng},
  title = {Bayesian-Based Pharmacokinetic Framework Integrated with Therapeutic Drug Monitoring for Assessing Adherence to Antiseizure Medications: A Clinical Trial Simulation Study},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  doi = {10.2196/77917}
}
Kostenlos starten →